Monthly News Roundup - March 2022
Adlarity Once-Weekly Patch Approved for Alzheimer’s Type Dementia In March, the FDA approved Adlarity (donepezil) Transdermal System from Corium Inc. Adlarity, an acetylcholinesterase inhibitor, is a once-weekly skin patch formulation... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 31, 2022 Category: Pharmaceuticals Source Type: news

Adlarity (Donepezil Hydrochloride) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 24, 2022 Category: Drugs & Pharmacology Source Type: news

FDA Clears Once-Weekly Transdermal Patch for Alzheimer's FDA Clears Once-Weekly Transdermal Patch for Alzheimer's
The once-weekly patch delivers consistent doses of donepezil through the skin, bypassing the digestive system and potentially leading to fewer GI side effects, the manufacturer notes.FDA Approvals (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - March 15, 2022 Category: Psychiatry Tags: Psychiatry News Alert Source Type: news

FDA Approves Adlarity (donepezil transdermal system) for Treatment of Patients with Alzheimer ’s Disease
BOSTON, March 14, 2022 /PRNewswire/ -- Corium, Inc., a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, announced today the U.S. Food and Drug Administration... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 14, 2022 Category: Drugs & Pharmacology Source Type: news

Donepezil Tied to Risk for Overactive Bladder
Risk for overactive bladder varies across individual cholinesterase inhibitor drugs (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - January 13, 2022 Category: Psychiatry Tags: Family Medicine, Geriatrics, Internal Medicine, Neurology, Pharmacy, Psychiatry, Urology, Journal, Source Type: news

Donepezil Tied to Risk for Overactive Bladder
THURSDAY, Jan. 13, 2022 -- There is an increased risk for overactive bladder (OAB) with the cholinesterase inhibitor (ChEI) donepezil versus rivastigmine, according to a study published online Dec. 2 in the Journal of the American Geriatrics... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 13, 2022 Category: Pharmaceuticals Source Type: news

Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for Adlarity (donepezil transdermal system) for the Treatment of Alzheimer ’s Disease
MENLO PARK, Calif., January 27, 2020 (GLOBE NEWSWIRE)– Corium, Inc., a commercial-stage biopharmaceutical company leading the development of novel transdermal healthcare products that are intended to provide alternative treatment options for... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - January 27, 2020 Category: Drugs & Pharmacology Source Type: news

donepezil (Aricept)
Title: donepezil (Aricept)Category: MedicationsCreated: 5/31/1998 12:00:00 AMLast Editorial Review: 10/15/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 15, 2019 Category: Drugs & Pharmacology Source Type: news

Alzheimer's Drug Linked to Potentially Serious Muscle Condition Alzheimer's Drug Linked to Potentially Serious Muscle Condition
Results of a large population-based cohort study support regulatory agency warnings about the risk for donepezil-induced rhabdomyolysis, a rare but potentially life-threatening condition.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 19, 2019 Category: Neurology Tags: Psychiatry News Source Type: news

Study: Common Alzheimer's disease drug doubles hospitalization risk
Donepezil, a common Alzheimer's disease drug, is linked to a two-fold higher risk of hospital admission than other cholinesterase inhibitors, a Canadian medical study found Monday. (Source: Health News - UPI.com)
Source: Health News - UPI.com - September 16, 2019 Category: Consumer Health News Source Type: news

Donepezil Ups Risk for Hospital Admission for Rhabdomyolysis
MONDAY, Sept. 16, 2019 -- Initiating donepezil to manage symptoms of Alzheimer disease or other dementias is associated with a higher risk for 30-day admission to the hospital with rhabdomyolysis compared with initiating rivastigmine or galantamine,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 16, 2019 Category: Pharmaceuticals Source Type: news

Rhabdomyolysis risk with donepezil double that of other AD meds
Rhabdomyolysis more likely in those starting donepezil compared with rivastigmine or galantamine Related items fromOnMedica Suicide no more likely in men on 5 α-reductase inhibitors NICE calls for safer use of controlled drugs Falls risk just as high with trazodone as antipsychotics Over 75s not taking medication correctly, say GPs Debate goes on over valproate in pregnancy (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 15, 2019 Category: UK Health Source Type: news

Study: Alzheimer's drug Aricept could reverse alcohol effects on young brains
An drug used to treat Alzheimer's disease could help reverse some of the negative effects of adolescent binge drinking on the brain, a study published Tuesday indicates. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 20, 2019 Category: Consumer Health News Source Type: news

Alzheimer's drug 'can reverse some of the brain damage caused by drinking too much alcohol'
Scientists at Duke University in the US gave donepezil to rats who had been exposed to excessive quantities of alcohol over the course of 16 days. (Source: the Mail online | Health)
Source: the Mail online | Health - August 20, 2019 Category: Consumer Health News Source Type: news

Prolonged QT syndrome due to donepezil: a reversible cause of falls? - Jackson EG, Stowe S.
We report a case of prolonged QT syndrome caused by donepezil which resulted in a fall and hip fracture. In this case... (Source: SafetyLit)
Source: SafetyLit - January 21, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news